Image

Relationship Between Gut Microbiome, Probiotics, and Mild Cognitive Impairment

Recruiting
40 - 80 years of age
Both
Phase N/A

Powered by AI

Overview

This study is to evaluate whether the consumption of probiotics can improve the symptoms of patients with mild cognitive impairment; also evaluate the effects of probiotics on patients' blood, oxidation and stress related indicators.

Description

Mild cognitive impairment (MCI) is the stage between the expected cognitive decline of normal aging and the more serious decline of dementia. It can involve problems with memory, language, thinking and judgment that are greater than normal age-related changes. Probiotics are regarded as active microorganisms. When consumed in sufficient amounts, participants can regulate intestinal flora, intestinal permeability, inflammation and antioxidant reactions in the body, and may produce host health, including delaying disease and regulating metabolic disease progression and prevent complications.

Eligibility

Inclusion Criteria:

  1. Patients who is suffering from Mild Cognitive Impairment.
  2. Clinical Dementia Rating (CDR) 0.5.
  3. Age 40-80 and willing to sign the Informed Consent.
  4. Education level is above the junior high school level.
  5. Healthy control who is eligible judged by PI.

Exclusion Criteria:

  1. Patients on antibiotics within the preceding one month.
  2. Patients using of other probiotic products (sachet, capsule or tablet) within the preceding two weeks.
  3. Have undergone surgery of liver, bladder, or gastrointestinal tract.
  4. Have current or history of inflammatory bowel disease.
  5. Have history of cancer.
  6. Known allergy to probiotics.
  7. Dementia (MMSE ≤ 23).
  8. Cognitive Impairment caused by head injury.
  9. History of cerebral apocalypse.
  10. Other possible diseases may cause cognitive impairment, such as: Parkinson's disease, cervical mass, hydrocephalus or epilepsy.
  11. Severely depressed patients (sick person health questionnaire-9 (PHQ-9) ≥ 20).
  12. Severe anxiety patients (Generalized Anxiety Dosorder 7-Item (GAD-7) ≧ 15).
  13. Undergoing medication treatment for acute illness, Organic psychosis or diagnosed as psychiatric illness within 3 months or poor control of chronic psychiatric illness.
  14. Undergoing parenteral nutrition.
  15. Not eligible judged by PI.

Study details

Mild Cognitive Impairment (MCI)

NCT04971096

Mackay Memorial Hospital

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.